Artificial intelligence has firmly established itself in the world of medicine. In diagnostic imaging, its use means greater precision, faster analysis, and improved patient care. Systems that support radiologists make a real contribution to the early detection of diseases, better interpretation of examination results, and more efficient management of clinical data.
AdventHealth Shawnee Mission, the Merriam-based hospital, is suing Blue Cross and Blue Shield of Kansas City, accusing the insurance provider of withholding more than $2 million in payments by wrongfully denying hundreds of medical diagnoses made by its physicians. Attorneys for the hospital said the insurance provider, also known as Blue KC, had contracted with Apixio, a firm that touts its use of artificial intelligence to review claims, to do audits of AdventHealth's diagnoses.
The federal government is using AI to crack down on health care fraud schemes. The AI-powered crackdown provides the feds with a tool to stay ahead of fraudsters and hasten investigations. The effort, orchestrated by DOJ, the FBI and HHS OIG, has led to criminal charges against 324 defendants, including 96 doctors, nurse practitioners, pharmacists and other medical professionals for alleged participation in healthcare fraud schemes.
On the second day of Mayo Clinic's AI Summit in Rochester, Dr. Matthew Callstrom shared where the health system stands with its use of generative artificial intelligence tools.
The two medtech giants aim to expand access to advanced patient monitoring technologies to deliver high-quality care. Their collaboration dates back to 1992 and the companies say the next phase “reflects both companies’ shared commitment to providing comprehensive and validated monitoring solutions that support better patient outcomes.” This partnership follows a stroke advocacy collaboration inked last fall.
The U.S. Food and Drug Administration (FDA) has announced an expansion of an earlier Medtronic recall, now issuing a new Class 1 recall for Medline Industries' procedure kits that contain Medtronic aortic root cannulas. The recalls indicate that there may be excess material in the male luer, which could potentially lead to serious adverse events, including procedure delays, neurological deficits, strokes, or even death.